Bistos

비스토스 · 419540

Health Care Medical Devices · KOSDAQ

Small-cap

Market cap US$8.9M (₩12.3B)

Overview

Bistos makes medical devices that monitor and care for unborn babies and newborns, including fetal heartbeat monitors, jaundice treatment units, and infant incubators, as well as breast pumps and general patient-monitoring equipment for broader clinical and home use.

Its products reach hospitals, clinics, and consumers across a wide range of countries, with the vast majority of its revenue coming from exports. Listed on KOSDAQ, Korea's tech and small-cap board, the company derives most of its sales from fetal and neonatal devices, though it has been steadily expanding into home-use and general medical equipment.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$12.4M
▼ −15.6% YoY
Operating profit · FY2025
−US$793.9K
Turned to loss
Net income · FY2025
−US$506.6K
Turned to loss

Revenue

  • FY2023US$15.4M
  • FY2024US$14.7M
  • FY2025US$12.4M

Operating profit

  • FY2023US$205.7K
  • FY2024US$225.7K
  • FY2025−US$793.9K

Net income

  • FY2023US$584.4K
  • FY2024US$614.2K
  • FY2025−US$506.6K

Key ratios (FY2025)

ROE
-3.9%
Debt/Eq
15.6%
Op. margin
-6.4%
Net margin
-4.1%
Rev. YoY
▼ −15.6%

Why it matters

Bistos describes itself as the sole domestic Korean supplier of fetal heartbeat monitors, supplying them directly to expectant mothers as well as to medical facilities.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.